Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment plans for pulmonary intermediate diseases such as the treatment and management of primary vascular disease require individualized development, usually including drug therapy, rehabilitation interventions, and regular follow-up multidimensional management.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive and endocrine diseases have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of interstitial pulmonary disease associated with coronary artery disease.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.